Insights

Early-stage biotech Small team scale and early funding indicate a high-need for scalable cloud and collaboration tools, cloud security, and cost-effective IT infrastructure that supports rapid R&D without heavy on-prem investments.

Biomolecular Learning Their focus on evolutionary biology, molecular recording, and advanced computing suggests opportunities to offer specialized computational platforms, data storage, and AI/ML tooling tailored for genetic medicine discovery.

Cloud and web stack Reliance on Wix, WordPress, Google Cloud, and React-based front-ends signals potential for web hosting, SaaS integrations, data visualization, and secure collaboration tools to scale outreach and partner engagement.

Funding leverage Recent funding of a few million dollars points to readiness to invest in strategic partnerships, CRO/CMO services, and joint development agreements to advance platform-ready therapeutics.

Market positioning Being a niche, early-stage biotech with references to industry peers suggests value in outreach focused on flexible licensing, co-development, and pilot programs with larger pharmaceutical players seeking novel modalities.

Similar companies to March Therapeutics

March Therapeutics Tech Stack

March Therapeutics uses 8 technology products and services including LiteSpeed Cache, Wix, WordPress, and more. Explore March Therapeutics's tech stack below.

  • LiteSpeed Cache
    Caching
  • Content Management System
  • Content Management System
  • Infrastructure As A Service
  • React
    Javascript Frameworks
  • jQuery
    Javascript Libraries
  • LiteSpeed
    Web Servers

March Therapeutics's Email Address Formats

March Therapeutics uses at least 1 email format:
March Therapeutics Email FormatsExamplePercentage
First@marchtx.comJohn@marchtx.com
100%

Frequently Asked Questions

What is March Therapeutics's official website and social media links?

Minus sign iconPlus sign icon
March Therapeutics's official website is marchtx.com and has social profiles on LinkedIn.

How much revenue does March Therapeutics generate?

Minus sign iconPlus sign icon
As of October 2026, March Therapeutics's annual revenue is estimated to be <$1M.

What is March Therapeutics's SIC code and NAICS code?

Minus sign iconPlus sign icon
March Therapeutics's SIC code is 8731 - Commercial Physical and Biological Research and NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does March Therapeutics have currently?

Minus sign iconPlus sign icon
As of October 2026, March Therapeutics has approximately 3 employees across 1 continents, including North America. Key team members include Founder And Cto: F. F. and Scientific Director, Discovery: N. G. Explore March Therapeutics's employee directory with LeadIQ.

What industry does March Therapeutics belong to?

Minus sign iconPlus sign icon
March Therapeutics operates in the Biotechnology Research industry.

What technology does March Therapeutics use?

Minus sign iconPlus sign icon
March Therapeutics's tech stack includes LiteSpeed Cache, Wix, WordPress, Google Workspace, Google Cloud, React, jQuery and LiteSpeed.

What is March Therapeutics's email format?

Minus sign iconPlus sign icon
March Therapeutics's email format typically follows the pattern of First@marchtx.com. Find more March Therapeutics email formats with LeadIQ.

How much funding has March Therapeutics raised to date?

Minus sign iconPlus sign icon
As of October 2026, March Therapeutics has raised $2.7M in funding. The last funding round occurred on Apr 01, 2020.

When was March Therapeutics founded?

Minus sign iconPlus sign icon
March Therapeutics was founded in 2020.
March Therapeutics logo

March Therapeutics

Biotechnology ResearchMassachusetts, United States2-10 Employees

March Therapeutics is a biotechnology research company focused on advancing genetic medicines. Its work centers on applying an evolutionary approach that combines molecular recording and advanced computing to identify and optimize novel protein modalities for therapeutic use, aiming to enhance the discovery and development process. The company serves researchers and developers in the biopharma space seeking innovative genetic medicine solutions, addressing challenges in discovering durable and effective protein-based therapies. Based in Cambridge, Massachusetts, the firm operates within the biotechnology research sector and emphasizes scientifically driven methods to mine natural diversity for therapeutic applications. The organization is small in size, reflecting its early-stage footprint in this specialized field, and recent developments include ongoing explorations into its Biomolecular Learning framework as a core avenue for its research activities.

Section iconCompany Overview

SIC Code
8731 - Commercial Physical and Biological Research
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2020
Employees
2-10

Section iconFunding & Financials

  • $2.7M

    March Therapeutics has raised a total of $2.7M of funding over 1 rounds. Their latest funding round was raised on Apr 01, 2020 as a Venture Round.

  • <$1M

    March Therapeutics's revenue is estimated to be in the range of <$1M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.